# Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

> **NCT03143985** · PHASE1 · COMPLETED · sponsor: **Koen van Besien** · enrollment: 18 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Vactosertib
- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT03143985
- **Lead sponsor:** Koen van Besien
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2022-02-27
- **Final completion:** 2022-09-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143985, "Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03143985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*